nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—TLR7—Trafficking and processing of endosomal TLR—CTSK—osteoporosis	0.0362	0.105	CbGpPWpGaD
Hydroxychloroquine—TLR9—Trafficking and processing of endosomal TLR—CTSK—osteoporosis	0.0286	0.0829	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IRAK3—osteoporosis	0.00718	0.0208	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—IRAK3—osteoporosis	0.0071	0.0206	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IRAK3—osteoporosis	0.00567	0.0164	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—IRAK3—osteoporosis	0.00561	0.0163	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—CTSK—osteoporosis	0.00538	0.0156	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—KL—osteoporosis	0.00518	0.015	CbGpPWpGaD
Hydroxychloroquine—Chloroquine—TNF—osteoporosis	0.00467	1	CrCbGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—KL—osteoporosis	0.00433	0.0126	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—AGER—osteoporosis	0.00427	0.0124	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—CTSK—osteoporosis	0.00425	0.0123	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—KL—osteoporosis	0.00421	0.0122	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—AGER—osteoporosis	0.00419	0.0121	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—KL—osteoporosis	0.00418	0.0121	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—KL—osteoporosis	0.00407	0.0118	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—KL—osteoporosis	0.00407	0.0118	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—AGER—osteoporosis	0.00404	0.0117	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—SPP1—osteoporosis	0.00359	0.0104	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—IRS2—osteoporosis	0.00355	0.0103	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—KL—osteoporosis	0.00338	0.00979	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—AGER—osteoporosis	0.00337	0.00977	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—AGER—osteoporosis	0.00331	0.0096	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—AGER—osteoporosis	0.0032	0.00926	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—IRS1—osteoporosis	0.0031	0.00898	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6R—osteoporosis	0.00305	0.00884	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—IL6R—osteoporosis	0.003	0.00868	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IRS2—osteoporosis	0.00297	0.0086	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6R—osteoporosis	0.00289	0.00838	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IRS2—osteoporosis	0.00289	0.00837	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—AGER—osteoporosis	0.00287	0.00833	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IRS2—osteoporosis	0.00286	0.00829	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—SPP1—osteoporosis	0.00284	0.00822	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—SPP1—osteoporosis	0.0028	0.00812	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IRS2—osteoporosis	0.00279	0.00808	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IRS2—osteoporosis	0.00279	0.00808	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IRS1—osteoporosis	0.00259	0.00751	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IRS1—osteoporosis	0.00252	0.0073	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IRS1—osteoporosis	0.0025	0.00724	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IL6R—osteoporosis	0.00243	0.00706	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IRS1—osteoporosis	0.00243	0.00705	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IRS1—osteoporosis	0.00243	0.00705	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6R—osteoporosis	0.00241	0.00699	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6R—osteoporosis	0.00237	0.00686	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IL6R—osteoporosis	0.00237	0.00686	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IL6R—osteoporosis	0.00235	0.0068	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IRS2—osteoporosis	0.00232	0.00671	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IGF1—osteoporosis	0.00231	0.00671	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IRAK3—osteoporosis	0.0023	0.00666	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6R—osteoporosis	0.00229	0.00662	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IL6R—osteoporosis	0.00229	0.00662	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IL6R—osteoporosis	0.00229	0.00662	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—AGER—osteoporosis	0.00227	0.00658	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IGF1—osteoporosis	0.00225	0.00653	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—SPP1—osteoporosis	0.00222	0.00642	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—ACTG1—osteoporosis	0.0021	0.00609	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—IL6R—osteoporosis	0.00205	0.00595	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL1B—osteoporosis	0.00203	0.00587	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IRS1—osteoporosis	0.00202	0.00586	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IL6R—osteoporosis	0.0019	0.0055	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IRAK3—osteoporosis	0.00182	0.00526	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CTSK—osteoporosis	0.00174	0.00505	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—NFATC1—osteoporosis	0.00171	0.00497	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—ACTG1—osteoporosis	0.00166	0.00482	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—IL6R—osteoporosis	0.00162	0.00471	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL1B—osteoporosis	0.0016	0.00464	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—osteoporosis	0.00158	0.00458	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00157	0.00455	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00155	0.00449	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TNF—osteoporosis	0.00147	0.00426	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CTSK—osteoporosis	0.00138	0.00399	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoporosis	0.00136	0.00394	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NFATC1—osteoporosis	0.00135	0.00393	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IRAK3—osteoporosis	0.00134	0.00388	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—IL6—osteoporosis	0.00133	0.00387	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoporosis	0.00129	0.00373	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.00127	0.00369	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL1B—osteoporosis	0.00125	0.00362	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ACTG1—osteoporosis	0.00122	0.00355	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	0.00119	0.00344	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—KL—osteoporosis	0.00118	0.00343	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TNF—osteoporosis	0.00116	0.00337	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TNF—osteoporosis	0.00115	0.00332	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SOST—osteoporosis	0.00112	0.00325	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Calcitriol—osteoporosis	0.0011	0.00169	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Ibandronate—osteoporosis	0.00109	0.00168	CcSEcCtD
Hydroxychloroquine—Pain—Raloxifene—osteoporosis	0.00109	0.00167	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00109	0.00167	CcSEcCtD
Hydroxychloroquine—Depression—Estradiol—osteoporosis	0.00109	0.00167	CcSEcCtD
Hydroxychloroquine—Fatigue—Ibandronate—osteoporosis	0.00109	0.00167	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IL6—osteoporosis	0.00108	0.00314	CbGpPWpGaD
Hydroxychloroquine—Leukopenia—Pamidronate—osteoporosis	0.00108	0.00166	CcSEcCtD
Hydroxychloroquine—Alopecia—Conjugated Estrogens—osteoporosis	0.00108	0.00166	CcSEcCtD
Hydroxychloroquine—Pain—Ibandronate—osteoporosis	0.00108	0.00166	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00108	0.00165	CcSEcCtD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoporosis	0.00107	0.00311	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Etidronic acid—osteoporosis	0.00107	0.00165	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Estropipate—osteoporosis	0.00107	0.00165	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Calcitriol—osteoporosis	0.00107	0.00165	CcSEcCtD
Hydroxychloroquine—Mental disorder—Conjugated Estrogens—osteoporosis	0.00107	0.00165	CcSEcCtD
Hydroxychloroquine—Oedema—Ethinyl Estradiol—osteoporosis	0.00106	0.00164	CcSEcCtD
Hydroxychloroquine—Malnutrition—Conjugated Estrogens—osteoporosis	0.00106	0.00164	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Pamidronate—osteoporosis	0.00106	0.00163	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—IRAK3—osteoporosis	0.00106	0.00307	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Alendronate—osteoporosis	0.00106	0.00163	CcSEcCtD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—osteoporosis	0.00105	0.00306	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IL6—osteoporosis	0.00105	0.00306	CbGpPWpGaD
Hydroxychloroquine—Pain—Calcitriol—osteoporosis	0.00105	0.00162	CcSEcCtD
Hydroxychloroquine—Convulsion—Pamidronate—osteoporosis	0.00105	0.00161	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—osteoporosis	0.00105	0.00303	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00104	0.00161	CcSEcCtD
Hydroxychloroquine—Tension—Conjugated Estrogens—osteoporosis	0.00104	0.0016	CcSEcCtD
Hydroxychloroquine—Urticaria—Estropipate—osteoporosis	0.00104	0.0016	CcSEcCtD
Hydroxychloroquine—Vision blurred—Zoledronate—osteoporosis	0.00104	0.0016	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Raloxifene—osteoporosis	0.00104	0.0016	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Etidronic acid—osteoporosis	0.00104	0.0016	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Estropipate—osteoporosis	0.00104	0.0016	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Estropipate—osteoporosis	0.00104	0.0016	CcSEcCtD
Hydroxychloroquine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00103	0.00159	CcSEcCtD
Hydroxychloroquine—Nervousness—Conjugated Estrogens—osteoporosis	0.00103	0.00159	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Ibandronate—osteoporosis	0.00103	0.00158	CcSEcCtD
Hydroxychloroquine—Urticaria—Alendronate—osteoporosis	0.00103	0.00158	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—RAP1A—osteoporosis	0.00102	0.00296	CbGpPWpGaD
Hydroxychloroquine—Body temperature increased—Alendronate—osteoporosis	0.00102	0.00157	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Alendronate—osteoporosis	0.00102	0.00157	CcSEcCtD
Hydroxychloroquine—Anaemia—Zoledronate—osteoporosis	0.00102	0.00157	CcSEcCtD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IL6—osteoporosis	0.00102	0.00295	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IL6—osteoporosis	0.00102	0.00295	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoporosis	0.00102	0.00295	CbGpPWpGaD
Hydroxychloroquine—Nervous system disorder—Risedronate—osteoporosis	0.00102	0.00157	CcSEcCtD
Hydroxychloroquine—Agitation—Zoledronate—osteoporosis	0.00101	0.00156	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—CTSK—osteoporosis	0.00101	0.00294	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTH1R—osteoporosis	0.00101	0.00294	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CALCR—osteoporosis	0.00101	0.00294	CbGpPWpGaD
Hydroxychloroquine—Angioedema—Zoledronate—osteoporosis	0.00101	0.00155	CcSEcCtD
Hydroxychloroquine—Skin disorder—Risedronate—osteoporosis	0.00101	0.00155	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Calcitriol—osteoporosis	0.00101	0.00155	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Raloxifene—osteoporosis	0.00101	0.00155	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Raloxifene—osteoporosis	0.00101	0.00155	CcSEcCtD
Hydroxychloroquine—Vision blurred—Conjugated Estrogens—osteoporosis	0.001	0.00154	CcSEcCtD
Hydroxychloroquine—Urticaria—Ibandronate—osteoporosis	0.001	0.00154	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—NFATC1—osteoporosis	0.000998	0.00289	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain—Ibandronate—osteoporosis	0.000995	0.00153	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Ibandronate—osteoporosis	0.000995	0.00153	CcSEcCtD
Hydroxychloroquine—Vertigo—Zoledronate—osteoporosis	0.000992	0.00153	CcSEcCtD
Hydroxychloroquine—Leukopenia—Zoledronate—osteoporosis	0.000988	0.00152	CcSEcCtD
Hydroxychloroquine—Oedema—Pamidronate—osteoporosis	0.000987	0.00152	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Estradiol—osteoporosis	0.000982	0.00151	CcSEcCtD
Hydroxychloroquine—Urticaria—Calcitriol—osteoporosis	0.000979	0.00151	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Estradiol—osteoporosis	0.000977	0.0015	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Calcitriol—osteoporosis	0.000974	0.0015	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Calcitriol—osteoporosis	0.000974	0.0015	CcSEcCtD
Hydroxychloroquine—Angioedema—Conjugated Estrogens—osteoporosis	0.000971	0.00149	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Zoledronate—osteoporosis	0.00097	0.00149	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—ACTG1—osteoporosis	0.000968	0.0028	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Estropipate—osteoporosis	0.000967	0.00149	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Pamidronate—osteoporosis	0.000967	0.00149	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Pamidronate—osteoporosis	0.000966	0.00149	CcSEcCtD
Hydroxychloroquine—Vomiting—Etidronic acid—osteoporosis	0.000965	0.00148	CcSEcCtD
Hydroxychloroquine—Rash—Etidronic acid—osteoporosis	0.000957	0.00147	CcSEcCtD
Hydroxychloroquine—Convulsion—Zoledronate—osteoporosis	0.000957	0.00147	CcSEcCtD
Hydroxychloroquine—Dermatitis—Etidronic acid—osteoporosis	0.000956	0.00147	CcSEcCtD
Hydroxychloroquine—Vertigo—Conjugated Estrogens—osteoporosis	0.000955	0.00147	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Alendronate—osteoporosis	0.000953	0.00147	CcSEcCtD
Hydroxychloroquine—Headache—Etidronic acid—osteoporosis	0.000951	0.00146	CcSEcCtD
Hydroxychloroquine—Asthenia—Estropipate—osteoporosis	0.000942	0.00145	CcSEcCtD
Hydroxychloroquine—Visual impairment—Estradiol—osteoporosis	0.000942	0.00145	CcSEcCtD
Hydroxychloroquine—Anorexia—Pamidronate—osteoporosis	0.00094	0.00145	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	0.000937	0.00272	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—KL—osteoporosis	0.000936	0.00271	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000934	0.00144	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000934	0.00144	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—AGER—osteoporosis	0.000931	0.0027	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Estropipate—osteoporosis	0.000929	0.00143	CcSEcCtD
Hydroxychloroquine—Asthenia—Alendronate—osteoporosis	0.000928	0.00143	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Ibandronate—osteoporosis	0.000928	0.00143	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—ADCY5—osteoporosis	0.000928	0.00269	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	0.000926	0.00268	CbGpPWpGaD
Hydroxychloroquine—Erythema multiforme—Estradiol—osteoporosis	0.000924	0.00142	CcSEcCtD
Hydroxychloroquine—Convulsion—Conjugated Estrogens—osteoporosis	0.000921	0.00142	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000919	0.00141	CcSEcCtD
Hydroxychloroquine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000918	0.00141	CcSEcCtD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—IL6—osteoporosis	0.000915	0.00265	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Alendronate—osteoporosis	0.000915	0.00141	CcSEcCtD
Hydroxychloroquine—Eye disorder—Estradiol—osteoporosis	0.000913	0.0014	CcSEcCtD
Hydroxychloroquine—Tinnitus—Estradiol—osteoporosis	0.000911	0.0014	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Calcitriol—osteoporosis	0.000908	0.0014	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TNF—osteoporosis	0.000907	0.00263	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Ibandronate—osteoporosis	0.000903	0.00139	CcSEcCtD
Hydroxychloroquine—Nausea—Etidronic acid—osteoporosis	0.000902	0.00139	CcSEcCtD
Hydroxychloroquine—Oedema—Zoledronate—osteoporosis	0.000901	0.00139	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000899	0.00138	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Estropipate—osteoporosis	0.000898	0.00138	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000896	0.00138	CcSEcCtD
Hydroxychloroquine—Fatigue—Risedronate—osteoporosis	0.000895	0.00138	CcSEcCtD
Hydroxychloroquine—Pruritus—Ibandronate—osteoporosis	0.000891	0.00137	CcSEcCtD
Hydroxychloroquine—Pain—Risedronate—osteoporosis	0.000887	0.00136	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Alendronate—osteoporosis	0.000885	0.00136	CcSEcCtD
Hydroxychloroquine—Asthenia—Calcitriol—osteoporosis	0.000884	0.00136	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Zoledronate—osteoporosis	0.000884	0.00136	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Zoledronate—osteoporosis	0.000882	0.00136	CcSEcCtD
Hydroxychloroquine—Somnolence—Pamidronate—osteoporosis	0.000877	0.00135	CcSEcCtD
Hydroxychloroquine—Skin disorder—Zoledronate—osteoporosis	0.000875	0.00135	CcSEcCtD
Hydroxychloroquine—Pruritus—Calcitriol—osteoporosis	0.000872	0.00134	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00087	0.00134	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Raloxifene—osteoporosis	0.00087	0.00134	CcSEcCtD
Hydroxychloroquine—Dizziness—Estropipate—osteoporosis	0.000868	0.00134	CcSEcCtD
Hydroxychloroquine—Oedema—Conjugated Estrogens—osteoporosis	0.000868	0.00133	CcSEcCtD
Hydroxychloroquine—Alopecia—Estradiol—osteoporosis	0.000864	0.00133	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Ibandronate—osteoporosis	0.000862	0.00133	CcSEcCtD
Hydroxychloroquine—Anorexia—Zoledronate—osteoporosis	0.000859	0.00132	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Pamidronate—osteoporosis	0.000858	0.00132	CcSEcCtD
Hydroxychloroquine—Mental disorder—Estradiol—osteoporosis	0.000856	0.00132	CcSEcCtD
Hydroxychloroquine—Dizziness—Alendronate—osteoporosis	0.000855	0.00132	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000852	0.00131	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000851	0.00131	CcSEcCtD
Hydroxychloroquine—Malnutrition—Estradiol—osteoporosis	0.000851	0.00131	CcSEcCtD
Hydroxychloroquine—Fatigue—Pamidronate—osteoporosis	0.000851	0.00131	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Risedronate—osteoporosis	0.000849	0.00131	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IL6—osteoporosis	0.000846	0.00245	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000846	0.0013	CcSEcCtD
Hydroxychloroquine—Pain—Pamidronate—osteoporosis	0.000844	0.0013	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Calcitriol—osteoporosis	0.000843	0.0013	CcSEcCtD
Hydroxychloroquine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000843	0.0013	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000841	0.00129	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000841	0.00129	CcSEcCtD
Hydroxychloroquine—Dizziness—Raloxifene—osteoporosis	0.000841	0.00129	CcSEcCtD
Hydroxychloroquine—Tension—Estradiol—osteoporosis	0.000835	0.00128	CcSEcCtD
Hydroxychloroquine—Vomiting—Estropipate—osteoporosis	0.000835	0.00128	CcSEcCtD
Hydroxychloroquine—Dizziness—Ibandronate—osteoporosis	0.000833	0.00128	CcSEcCtD
Hydroxychloroquine—Rash—Estropipate—osteoporosis	0.000828	0.00127	CcSEcCtD
Hydroxychloroquine—Dermatitis—Estropipate—osteoporosis	0.000827	0.00127	CcSEcCtD
Hydroxychloroquine—Anorexia—Conjugated Estrogens—osteoporosis	0.000827	0.00127	CcSEcCtD
Hydroxychloroquine—Nervousness—Estradiol—osteoporosis	0.000826	0.00127	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000826	0.00239	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Risedronate—osteoporosis	0.000824	0.00127	CcSEcCtD
Hydroxychloroquine—Headache—Estropipate—osteoporosis	0.000823	0.00127	CcSEcCtD
Hydroxychloroquine—Vomiting—Alendronate—osteoporosis	0.000822	0.00126	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Risedronate—osteoporosis	0.00082	0.00126	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Risedronate—osteoporosis	0.00082	0.00126	CcSEcCtD
Hydroxychloroquine—Rash—Alendronate—osteoporosis	0.000816	0.00125	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PSMA2—osteoporosis	0.000815	0.00236	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PSMA5—osteoporosis	0.000815	0.00236	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Alendronate—osteoporosis	0.000815	0.00125	CcSEcCtD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000815	0.00236	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IRS2—osteoporosis	0.000812	0.00235	CbGpPWpGaD
Hydroxychloroquine—Headache—Alendronate—osteoporosis	0.00081	0.00125	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—RAP1A—osteoporosis	0.000809	0.00234	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Raloxifene—osteoporosis	0.000809	0.00124	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000807	0.00124	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—MGLL—osteoporosis	0.000805	0.00233	CbGpPWpGaD
Hydroxychloroquine—Rash—Raloxifene—osteoporosis	0.000802	0.00123	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—CTSK—osteoporosis	0.000802	0.00232	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Raloxifene—osteoporosis	0.000801	0.00123	CcSEcCtD
Hydroxychloroquine—Somnolence—Zoledronate—osteoporosis	0.000801	0.00123	CcSEcCtD
Hydroxychloroquine—Vomiting—Ibandronate—osteoporosis	0.000801	0.00123	CcSEcCtD
Hydroxychloroquine—Headache—Raloxifene—osteoporosis	0.000797	0.00123	CcSEcCtD
Hydroxychloroquine—Rash—Ibandronate—osteoporosis	0.000794	0.00122	CcSEcCtD
Hydroxychloroquine—Dermatitis—Ibandronate—osteoporosis	0.000793	0.00122	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—NFATC1—osteoporosis	0.000789	0.00229	CbGpPWpGaD
Hydroxychloroquine—Headache—Ibandronate—osteoporosis	0.000789	0.00121	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—LRP5—osteoporosis	0.000785	0.00228	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000784	0.00121	CcSEcCtD
Hydroxychloroquine—Vomiting—Calcitriol—osteoporosis	0.000784	0.00121	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Zoledronate—osteoporosis	0.000783	0.0012	CcSEcCtD
Hydroxychloroquine—Agitation—Estradiol—osteoporosis	0.000782	0.0012	CcSEcCtD
Hydroxychloroquine—Nausea—Estropipate—osteoporosis	0.00078	0.0012	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Pamidronate—osteoporosis	0.00078	0.0012	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Pamidronate—osteoporosis	0.00078	0.0012	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000778	0.0012	CcSEcCtD
Hydroxychloroquine—Angioedema—Estradiol—osteoporosis	0.000777	0.0012	CcSEcCtD
Hydroxychloroquine—Rash—Calcitriol—osteoporosis	0.000777	0.0012	CcSEcCtD
Hydroxychloroquine—Fatigue—Zoledronate—osteoporosis	0.000777	0.00119	CcSEcCtD
Hydroxychloroquine—Dermatitis—Calcitriol—osteoporosis	0.000777	0.00119	CcSEcCtD
Hydroxychloroquine—Headache—Calcitriol—osteoporosis	0.000772	0.00119	CcSEcCtD
Hydroxychloroquine—Somnolence—Conjugated Estrogens—osteoporosis	0.000771	0.00119	CcSEcCtD
Hydroxychloroquine—Pain—Zoledronate—osteoporosis	0.000771	0.00119	CcSEcCtD
Hydroxychloroquine—Nausea—Alendronate—osteoporosis	0.000768	0.00118	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Risedronate—osteoporosis	0.000765	0.00118	CcSEcCtD
Hydroxychloroquine—Vertigo—Estradiol—osteoporosis	0.000764	0.00118	CcSEcCtD
Hydroxychloroquine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000764	0.00117	CcSEcCtD
Hydroxychloroquine—Nausea—Raloxifene—osteoporosis	0.000756	0.00116	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000754	0.00116	CcSEcCtD
Hydroxychloroquine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000753	0.00116	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—LRP6—osteoporosis	0.000751	0.00218	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000749	0.00115	CcSEcCtD
Hydroxychloroquine—Fatigue—Conjugated Estrogens—osteoporosis	0.000748	0.00115	CcSEcCtD
Hydroxychloroquine—Nausea—Ibandronate—osteoporosis	0.000748	0.00115	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Estradiol—osteoporosis	0.000748	0.00115	CcSEcCtD
Hydroxychloroquine—Asthenia—Risedronate—osteoporosis	0.000745	0.00115	CcSEcCtD
Hydroxychloroquine—Pain—Conjugated Estrogens—osteoporosis	0.000742	0.00114	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000737	0.00113	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—AGER—osteoporosis	0.000736	0.00213	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Risedronate—osteoporosis	0.000734	0.00113	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—ADCY5—osteoporosis	0.000733	0.00212	CbGpPWpGaD
Hydroxychloroquine—Nausea—Calcitriol—osteoporosis	0.000732	0.00113	CcSEcCtD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	0.000732	0.00212	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000728	0.00112	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Pamidronate—osteoporosis	0.000727	0.00112	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—IL6—osteoporosis	0.000723	0.0021	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000719	0.00111	CcSEcCtD
Hydroxychloroquine—Urticaria—Zoledronate—osteoporosis	0.000716	0.0011	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Zoledronate—osteoporosis	0.000712	0.0011	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Zoledronate—osteoporosis	0.000712	0.0011	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Risedronate—osteoporosis	0.00071	0.00109	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00071	0.00109	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IRS1—osteoporosis	0.000708	0.00205	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Pamidronate—osteoporosis	0.000708	0.00109	CcSEcCtD
Hydroxychloroquine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000704	0.00108	CcSEcCtD
Hydroxychloroquine—Pruritus—Pamidronate—osteoporosis	0.000698	0.00107	CcSEcCtD
Hydroxychloroquine—Oedema—Estradiol—osteoporosis	0.000694	0.00107	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—KL—osteoporosis	0.00069	0.002	CbGpPWpGaD
Hydroxychloroquine—Urticaria—Conjugated Estrogens—osteoporosis	0.000689	0.00106	CcSEcCtD
Hydroxychloroquine—Dizziness—Risedronate—osteoporosis	0.000686	0.00106	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000686	0.00105	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000686	0.00105	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Estradiol—osteoporosis	0.000681	0.00105	CcSEcCtD
Hydroxychloroquine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000677	0.00104	CcSEcCtD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	0.000677	0.00196	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Pamidronate—osteoporosis	0.000675	0.00104	CcSEcCtD
Hydroxychloroquine—Skin disorder—Estradiol—osteoporosis	0.000675	0.00104	CcSEcCtD
Hydroxychloroquine—Rash—Ethinyl Estradiol—osteoporosis	0.000671	0.00103	CcSEcCtD
Hydroxychloroquine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000671	0.00103	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000669	0.00194	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	0.000667	0.00193	CbGpPWpGaD
Hydroxychloroquine—Headache—Ethinyl Estradiol—osteoporosis	0.000667	0.00103	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—IL6R—osteoporosis	0.000666	0.00193	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Zoledronate—osteoporosis	0.000664	0.00102	CcSEcCtD
Hydroxychloroquine—Vomiting—Risedronate—osteoporosis	0.00066	0.00101	CcSEcCtD
Hydroxychloroquine—Rash—Risedronate—osteoporosis	0.000654	0.00101	CcSEcCtD
Hydroxychloroquine—Dermatitis—Risedronate—osteoporosis	0.000654	0.00101	CcSEcCtD
Hydroxychloroquine—Dizziness—Pamidronate—osteoporosis	0.000652	0.001	CcSEcCtD
Hydroxychloroquine—Headache—Risedronate—osteoporosis	0.00065	0.001	CcSEcCtD
Hydroxychloroquine—Asthenia—Zoledronate—osteoporosis	0.000647	0.000994	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—PSMA5—osteoporosis	0.000644	0.00187	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PSMA2—osteoporosis	0.000644	0.00187	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IRS2—osteoporosis	0.000642	0.00186	CbGpPWpGaD
Hydroxychloroquine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000639	0.000983	CcSEcCtD
Hydroxychloroquine—Pruritus—Zoledronate—osteoporosis	0.000638	0.000981	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—TLN1—osteoporosis	0.000634	0.00184	CbGpPWpGaD
Hydroxychloroquine—Nausea—Ethinyl Estradiol—osteoporosis	0.000632	0.000972	CcSEcCtD
Hydroxychloroquine—Vomiting—Pamidronate—osteoporosis	0.000627	0.000965	CcSEcCtD
Hydroxychloroquine—Asthenia—Conjugated Estrogens—osteoporosis	0.000623	0.000957	CcSEcCtD
Hydroxychloroquine—Rash—Pamidronate—osteoporosis	0.000622	0.000957	CcSEcCtD
Hydroxychloroquine—Dermatitis—Pamidronate—osteoporosis	0.000621	0.000956	CcSEcCtD
Hydroxychloroquine—Headache—Pamidronate—osteoporosis	0.000618	0.000951	CcSEcCtD
Hydroxychloroquine—Somnolence—Estradiol—osteoporosis	0.000617	0.000949	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Zoledronate—osteoporosis	0.000617	0.000948	CcSEcCtD
Hydroxychloroquine—Nausea—Risedronate—osteoporosis	0.000616	0.000948	CcSEcCtD
Hydroxychloroquine—Pruritus—Conjugated Estrogens—osteoporosis	0.000614	0.000944	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Estradiol—osteoporosis	0.000604	0.000928	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Estradiol—osteoporosis	0.0006	0.000922	CcSEcCtD
Hydroxychloroquine—Fatigue—Estradiol—osteoporosis	0.000599	0.000921	CcSEcCtD
Hydroxychloroquine—Dizziness—Zoledronate—osteoporosis	0.000596	0.000916	CcSEcCtD
Hydroxychloroquine—Pain—Estradiol—osteoporosis	0.000594	0.000913	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000594	0.000913	CcSEcCtD
Hydroxychloroquine—Nausea—Pamidronate—osteoporosis	0.000586	0.000901	CcSEcCtD
Hydroxychloroquine—Dizziness—Conjugated Estrogens—osteoporosis	0.000574	0.000882	CcSEcCtD
Hydroxychloroquine—Vomiting—Zoledronate—osteoporosis	0.000573	0.000881	CcSEcCtD
Hydroxychloroquine—Rash—Zoledronate—osteoporosis	0.000568	0.000874	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Estradiol—osteoporosis	0.000568	0.000873	CcSEcCtD
Hydroxychloroquine—Dermatitis—Zoledronate—osteoporosis	0.000568	0.000873	CcSEcCtD
Hydroxychloroquine—Headache—Zoledronate—osteoporosis	0.000565	0.000868	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—IRS1—osteoporosis	0.00056	0.00162	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Conjugated Estrogens—osteoporosis	0.000552	0.000848	CcSEcCtD
Hydroxychloroquine—Urticaria—Estradiol—osteoporosis	0.000552	0.000848	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Estradiol—osteoporosis	0.000549	0.000844	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Estradiol—osteoporosis	0.000549	0.000844	CcSEcCtD
Hydroxychloroquine—Rash—Conjugated Estrogens—osteoporosis	0.000547	0.000841	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—P4HB—osteoporosis	0.000547	0.00158	CbGpPWpGaD
Hydroxychloroquine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000547	0.000841	CcSEcCtD
Hydroxychloroquine—TLR9—Immune System—KL—osteoporosis	0.000545	0.00158	CbGpPWpGaD
Hydroxychloroquine—Headache—Conjugated Estrogens—osteoporosis	0.000544	0.000836	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—AGER—osteoporosis	0.000542	0.00157	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ADCY5—osteoporosis	0.00054	0.00157	CbGpPWpGaD
Hydroxychloroquine—Nausea—Zoledronate—osteoporosis	0.000535	0.000823	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—PTH—osteoporosis	0.000532	0.00154	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6R—osteoporosis	0.000526	0.00152	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RAP1A—osteoporosis	0.000523	0.00152	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CNR2—osteoporosis	0.000519	0.0015	CbGpPWpGaD
Hydroxychloroquine—Nausea—Conjugated Estrogens—osteoporosis	0.000515	0.000793	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Estradiol—osteoporosis	0.000512	0.000787	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—NFATC1—osteoporosis	0.00051	0.00148	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—DKK1—osteoporosis	0.000506	0.00147	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Estradiol—osteoporosis	0.000498	0.000766	CcSEcCtD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000496	0.00144	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Estradiol—osteoporosis	0.000491	0.000756	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—WNT1—osteoporosis	0.000488	0.00141	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Estradiol—osteoporosis	0.000475	0.000731	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FGA—osteoporosis	0.000474	0.00137	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IRS2—osteoporosis	0.000473	0.00137	CbGpPWpGaD
Hydroxychloroquine—Dizziness—Estradiol—osteoporosis	0.000459	0.000706	CcSEcCtD
Hydroxychloroquine—Vomiting—Estradiol—osteoporosis	0.000442	0.000679	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—BMP2—osteoporosis	0.000441	0.00128	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTHLH—osteoporosis	0.000441	0.00128	CbGpPWpGaD
Hydroxychloroquine—Rash—Estradiol—osteoporosis	0.000438	0.000673	CcSEcCtD
Hydroxychloroquine—Dermatitis—Estradiol—osteoporosis	0.000437	0.000673	CcSEcCtD
Hydroxychloroquine—Headache—Estradiol—osteoporosis	0.000435	0.000669	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling Pathways—FGB—osteoporosis	0.000431	0.00125	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AGER—osteoporosis	0.000429	0.00124	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ADCY5—osteoporosis	0.000427	0.00124	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PSMA5—osteoporosis	0.000417	0.00121	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PSMA2—osteoporosis	0.000417	0.00121	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IRS1—osteoporosis	0.000413	0.0012	CbGpPWpGaD
Hydroxychloroquine—Nausea—Estradiol—osteoporosis	0.000412	0.000634	CcSEcCtD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000402	0.00117	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—CALCA—osteoporosis	0.000388	0.00112	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6R—osteoporosis	0.000388	0.00112	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IRS2—osteoporosis	0.000374	0.00108	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	0.000355	0.00103	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—KL—osteoporosis	0.000352	0.00102	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	0.000351	0.00102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IRS1—osteoporosis	0.000326	0.000945	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6R—osteoporosis	0.000306	0.000888	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—osteoporosis	0.000296	0.000859	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL1B—osteoporosis	0.000295	0.000854	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ADCY5—osteoporosis	0.000276	0.0008	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SPP1—osteoporosis	0.000267	0.000774	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IRS2—osteoporosis	0.000242	0.0007	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LEP—osteoporosis	0.000236	0.000685	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—osteoporosis	0.000234	0.000679	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL1B—osteoporosis	0.000233	0.000675	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ESR1—osteoporosis	0.000226	0.000654	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—POMC—osteoporosis	0.000214	0.000619	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IRS1—osteoporosis	0.000211	0.000611	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—POMC—osteoporosis	0.000203	0.000588	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—FDPS—osteoporosis	0.000201	0.000584	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PKM—osteoporosis	0.000201	0.000584	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6R—osteoporosis	0.000198	0.000574	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF1—osteoporosis	0.000195	0.000566	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PGLS—osteoporosis	0.000191	0.000553	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GPD2—osteoporosis	0.000191	0.000553	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ATIC—osteoporosis	0.000175	0.000506	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PNP—osteoporosis	0.000175	0.000506	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6—osteoporosis	0.000173	0.0005	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—OXCT1—osteoporosis	0.000149	0.00043	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CA2—osteoporosis	0.000149	0.00043	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MGLL—osteoporosis	0.000145	0.000419	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—osteoporosis	0.000136	0.000396	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—IDH2—osteoporosis	0.000123	0.000357	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MYC—osteoporosis	0.000117	0.00034	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TGFB1—osteoporosis	0.000117	0.000339	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP27A1—osteoporosis	0.000116	0.000335	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ACP5—osteoporosis	0.000113	0.000326	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TPI1—osteoporosis	0.000105	0.000303	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—P4HB—osteoporosis	9.84e-05	0.000285	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GAPDH—osteoporosis	9.66e-05	0.00028	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—RAP1A—osteoporosis	9.41e-05	0.000273	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—osteoporosis	8.83e-05	0.000256	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ENO1—osteoporosis	7.6e-05	0.00022	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PSMA2—osteoporosis	7.49e-05	0.000217	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PSMA5—osteoporosis	7.49e-05	0.000217	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP19A1—osteoporosis	6.08e-05	0.000176	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ADCY5—osteoporosis	4.97e-05	0.000144	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GPX1—osteoporosis	4.95e-05	0.000143	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTHFR—osteoporosis	4.57e-05	0.000132	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—POMC—osteoporosis	3.65e-05	0.000106	CbGpPWpGaD
